In an individual participant data meta-analysis of four adjuvant chemotherapy trials (7264 patients, non-metastatic colorectal cancer), higher BMI was not associated with overall survival (HR 0.98 per 5 kg/m2) but was linked to lower cumulative chemotherapy dose.
Meta-analysisn = 7,264
Slawinski et al. Body mass index, adjuvant chemotherapy, toxicity, and survival in non-metastatic colorectal cancer: an individual participant data meta-analysis (OCTOPUS)